{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 408087713
| IUPAC_name = (6''S'',8''S'',9''S'',10''R'',11''S'',13''R'',14''S'',17''S'')- 17-acetyl-11-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,<br />11,12,14,15,16,17- dodecahydrocyclopenta[a] phenanthren-3-one
| image = Medrysone.svg
| width = 250
<!--Clinical data-->
| tradename = HMS, Medrocort, others
| Drugs.com = {{drugs.com|CONS|medrysone}}
| MedlinePlus = a606003
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US_comment = Discontinued
| legal_status = 
| routes_of_administration = Eye drops
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!--Identifiers-->
| IUPHAR_ligand = 7086
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 2668-66-8
| ATC_prefix = S01
| ATC_suffix = BA08
| ATC_supplemental = 
| PubChem = 247839
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00253
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 216968
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = D2UFC189XF
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02289
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201173
<!--Chemical data-->
| C=22 | H=32 | O=3
| molecular_weight = 344.488 g/mol
| smiles = C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI=1S/C22H32O3/c1-12-9-15-17-6-5-16(13(2)23)22(17,4)11-19(25)20(15)21(3)8-7-14(24)10-18(12)21/h10,12,15-17,19-20,25H,5-9,11H2,1-4H3/t12-,15-,16+,17-,19-,20+,21-,22+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = GZENKSODFLBBHQ-ILSZZQPISA-N
| synonyms = NSC-63278; Hydroxymethylprogesterone; Methylhydroxyprogesterone; Hydroxymesterone; 6α-Methyl-11β-hydroxyprogesterone; 6α-Methyl-11β-hydroxypregn-4-ene-3,20-dione
}}

'''Medrysone''' ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]]) (brand names '''HMS''', '''Medrocort''', others; former developmental code name '''NSC-63278'''), also known as '''hydroxymethylprogesterone''', '''methylhydroxyprogesterone''', or '''hydroxymesterone''', as well as '''6α-methyl-11β-hydroxyprogesterone''' or '''6α-methyl-11β-hydroxypregn-4-ene-3,20-dione''', is a [[synthetic compound|synthetic]] [[glucocorticoid]] that is or has been used in the treatment of [[inflammation|inflammatory]] [[eye disease]]s.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA760|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=760–}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA640|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=640–}}</ref><ref name="MortonHall1999">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=mqaOMOtk61IC&pg=PA173|date=31 October 1999|publisher=Springer Science & Business Media|isbn=978-0-7514-0499-9|pages=173–}}</ref> It has been discontinued in the [[United States]].<ref name="Drugs.com">https://www.drugs.com/pro/hms.html</ref> Although it is very similar in [[chemical structure|structure]] to [[progesterone]],<ref name="pmid5764682">{{cite journal | vauthors = Bedrossian RH, Eriksen SP | title = The treatment of ocular inflammation with medrysone | journal = Arch. Ophthalmol. | volume = 81 | issue = 2 | pages = 184–91 | year = 1969 | pmid = 5764682 | doi = | url = }}</ref> neither [[progestogen]]ic nor [[androgen]]ic activity has been demonstrated for or attributed to medrysone.<ref name="pmid5327794">{{cite journal | vauthors = Spaeth GL | title = Hydroxymethylprogesterone. An anti-inflammatory steroid without apparent effect on intraocular pressure | journal = Arch. Ophthalmol. | volume = 75 | issue = 6 | pages = 783–7 | year = 1966 | pmid = 5327794 | doi = | url = }}</ref><ref name="pmid5172545">{{cite journal | vauthors = Schwartz A, Leopold IH | title = Topical anti-inflammatory steroids and intraocular pressure: the place of medrysone | journal = Drugs | volume = 2 | issue = 1 | pages = 1–4 | year = 1971 | pmid = 5172545 | doi = | url = }}</ref><ref name="pmid5554878">{{cite journal | vauthors = Smolin G | title = Medrysone hypersensitivity. Report of a case | journal = Arch. Ophthalmol. | volume = 85 | issue = 4 | pages = 478–9 | year = 1971 | pmid = 5554878 | doi = | url = }}</ref>

==See also==
* [[9α-Bromo-11-ketoprogesterone]]
* [[11β-Hydroxyprogesterone]]
* [[Endrisone]]
* [[Flugestone]]
* [[Fluorometholone]]

==References==
{{Reflist|2}}


{{Glucocorticoids and antiglucocorticoids}}
{{Glucocorticoid receptor modulators}}

[[Category:Alcohols]]
[[Category:Diketones]]
[[Category:Glucocorticoids]]
[[Category:Pregnanes]]


{{steroid-stub}}